For Built In NYC’s companies to keep a close eye on in 2021, it’s not a matter of “if they will grow” — it’s just a matter of “how.”
Thirty Madison, a direct-to-consumer chronic health treatment startup, raised $47 million last August to continue expanding its platform. Emergency response data platform RapidSOS raised $85 million last month to further its reach. And, just a week following, Butterfly Network, the creator of the handheld ultrasound monitoring device Butterfly IQ, had its initial public offering on the NYSE.
Below, Built In NYC talked with leaders from the three companies on their outlook for the year ahead and the impact they’re looking to drive for their users and industries.
What they do: Butterfly Network is the creator of the handheld ultrasound monitoring device Butterfly IQ. They also provide point-of-care ultrasound operating software for use by medical professionals.
One of the most important focuses for Butterfly Network in the coming months: “At Butterfly, we continue to push our mission to democratize healthcare for all,” Molinari said. “We recently went public and are continuing to drive our growth. Our most critical focus in the coming months is the expansion of our software engineering and technical staff at all levels, with a particular focus on cloud, mobile engineering, AI and enterprise architecture. This will allow us to further develop our technology. We’re also very focused on growing our sales team to make sure our product is accessible to the world.”
What we are working on will literally change how medical care is delivered throughout the world.”
What impact this will have on Butterfly Network and/or its industry: “Butterfly is revolutionizing healthcare,” Molinari said. “That sounds very lofty but what we are working on will literally change how medical care is delivered throughout the world. This promise is a once-in-a-lifetime opportunity.”
“By growing both the teams who develop our technology and teams who sell our technology, we allow Butterfly Network to seize this opportunity to impact healthcare. We will fulfill our mission and our promise to the world to innovate for the democratization of healthcare for all.”
What they do: RapidSOS’ emergency response data platform provides emergency response teams with immediate data about 911 callers and the situations they’re in.
One of the most important focuses for RapidSOS in the coming months: “RapidSOS recently closed $85M in Series C funding led by Insight Partners, and the investment, which brings RapidSOS’s total funding to $200 million, will advance the company’s work to connect emergency intelligence data with first responders during emergencies,” Martin said. “With this support, RapidSOS plans to hire talent that will accelerate its partnerships with tech partners and public safety globally, supporting first responders’ life-saving work with critical data from hundreds of millions of devices.”
“Working together with our RapidSOS Ready partner community, we’re committed to solving the 911 data challenge: to deliver the right data, at the right time, and ensure first responders have the information they need when it matters most. We would like to see our technology in every emergency communication center (ECC) around the world, providing important, mission-critical information in real-time to telecommunicators and first responders to make their jobs easier on the ground and improve emergency outcomes.”
In 2020 alone, data from the RapidSOS Platform was used in over 150 million emergencies.”
What impact this will have on RapidSOS and its industry: “While technology has dramatically transformed our lives over the past 60 years, when our lives are on the line, we rely on a 911 infrastructure that was built in the 1960s and has not been modernized to better respond to today’s emergency situations,” Martin said.
“Our mission at RapidSOS is to overcome this challenge and help first responders save more lives by empowering faster emergency response, ensuring that accurate emergency intelligence data is immediately available to 911, and enabling first responders to arrive on scene faster and more informed.”
“In 2020 alone, data from the RapidSOS Platform was used in over 150 million emergencies and became the critical link between citizens and first responders, even when traditional voice 911 circuits went down in major natural disasters and incidents such as the 2020 Nashville Bombing.”
What they do: Thirty Madison offers direct-to-consumer treatments for hair loss, migraines and chronic acid reflux.
One of the most important focuses for Thirty Madison in the coming months: “Since 2018, Thirty Madison has launched four businesses focused on different chronic conditions - Keeps, Cove, Evens and Picnic, which was launched this month,” Karagas said. “Each new condition requires thoughtful researching, planning, building and execution as we prepare to launch. It is a total team effort to fully understand the needs of the consumer, partnering with medical experts to create the right care model, and building out the technology that will enable every patient to get the best, specialized care.”
“Right now we are focused on accelerating our expansion into new conditions. It begins by building a best-in-class team across research, strategy, operations, engineering, marketing, product and design to bring new brands to market. This team will serve as a center of excellence internally, enabling us to launch and scale new businesses more quickly and efficiently over time. We will also continue to build upon our platform capabilities to ensure we’re able to provide the best end-to-end care for patients across the spectrum of chronic conditions. To achieve these goals we are building a diverse team of the brightest minds with a passion for transforming healthcare.”
Thirty Madison has the opportunity to become the premier healthcare company for patients living with chronic conditions.”
What impact this will have on Thirty Madison and/or its industry: “Our model delivers superior health outcomes at a cost and scale that has never been possible before. Expanding into new conditions enables us to have a positive impact on more patients and advance our vision to transform the way that chronic conditions are treated, making the healthcare system more innovative, patient-focused, affordable, and accessible,” Karagas said.
“Our business will continue to grow two to three times annually as we expand our offerings. This will create tremendous opportunities for career advancement and driving change within a broken industry. Thirty Madison has the opportunity to become the premier healthcare company for patients living with chronic conditions, and the next few years will be critical in our journey to transform healthcare.”
